THE FEARED THERAPIST: ON BEING PART OF THE PSYCHOTIC PATIENT'S PARANOID DELUSION

2020 ◽  
Author(s):  
NARDUS SAAYMAN
Keyword(s):  
Paranoid Delusion

scholarly journals A Case Report on Management of Father Daughter Incest with Schizophrenia

2016 ◽  
Vol 2016 ◽  
pp. 1-3
Author(s):  
Tanjir Rashid Soron
Keyword(s):  
Public Health ◽  
Sexual Behavior ◽  
Case Report ◽  
Sexual Dysfunction ◽  
Sexually Abused ◽  
Attempted Suicide ◽  
Auditory Hallucination ◽  
Public Health Problem ◽  
Main Concern ◽  
Paranoid Delusion

Incest is a neglected and hidden public health problem. This case is about a patient who was victim of sexual abuse, suffered from schizophrenia and abused his biological daughter. He was physically and sexually abused by seniors and classmates, developed paranoid delusion and auditory hallucination. During the course of the illness, he was hospitalized several times as a case of schizophrenia and sexual dysfunction was his main concern. The patient’s illness followed a waxing and waning course. He took medication on on-and-off basis. He abused his biological daughter sexually at the later stage of the illness. Ultimately, the patient attempted suicide after an indecent sexual act with another relative and he was admitted to the hospital. He was treated with risperidone that was titrated to 10 mg per day. After continuing the medication for 2 years he regained a functioning life and remained stable with medication. This case shows the importance of exploring the sexual behavior of the patients and sharing the experience may help in the treatment of schizophrenia patients with incest.

Paranoid delusion as lead symptom in two siblings with late-onset Tay–Sachs disease and a novel mutation in the HEXA gene

2015 ◽  
Vol 262 (4) ◽  
pp. 1072-1073 ◽  
Author(s):  
Claudia Stendel ◽  
Constanze Gallenmüller ◽  
Katrin Peters ◽  
Friederike Bürger ◽  
Gwendolyn Gramer ◽  
...  
Keyword(s):  
Late Onset ◽  
Novel Mutation ◽  
Tay Sachs Disease ◽  
Hexa Gene ◽  
Paranoid Delusion

A CASE REPORT OF PARANOID DELUSION WITH GALANTAMINE USE

2005 ◽  
Vol 53 (11) ◽  
pp. 2036-2037 ◽  
Author(s):  
Abid Iraqi ◽  
Terry Lynn Hughes
Keyword(s):  
Case Report ◽  
Paranoid Delusion

scholarly journals Myxedema Psychosis after Levothyroxine Withdrawal in Radioactive Iodine Treatment of Differentiated Thyroid Cancer: A Case Report

2021 ◽  
pp. 1596-1600
Author(s):  
Nutnicha Pattaravimonporn ◽  
Thanat Chaikijurajai ◽  
Wichana Chamroonrat ◽  
Chutintorn Sriphrapradang
Keyword(s):  
Radioactive Iodine ◽  
Auditory Hallucination ◽  
Neuropsychiatric Symptoms ◽  
Hormone Replacement ◽  
Signs And Symptoms ◽  
Psychotic Symptoms ◽  
Acute Psychosis ◽  
Paranoid Delusion ◽  
Thyroid Hormone Replacement Therapy ◽  
Iodine Treatment

Neuropsychiatric symptoms, especially acute psychosis (often referred to as myxedema madness or psychosis), are rare but possible clinical presentations of patients with hypothyroidism. A 42-year-old woman with papillary thyroid carcinoma and recent total thyroidectomy had developed flat affect, paranoid delusion, and visual and auditory hallucination during inpatient admission for elective radioactive iodine treatment. On admission, her history and physical exam did not reveal symptoms and signs of significant hypothyroidism. Other medical causes of acute psychosis were excluded, and the patient was immediately treated with thyroid hormone replacement therapy. Subsequently, her thyroid function normalized, and her psychotic symptoms gradually improved. Although there is a lack of classic signs and symptoms of hypothyroidism, myxedema madness should be recognized as one of the potentially treatable causes of acute psychosis.

Caffeine and Caffeinism

1989 ◽  
Vol 75 (2) ◽  
pp. 65-67
Author(s):  
D. C. Mackay ◽  
J. W. Rollins
Keyword(s):  
Differential Diagnosis ◽  
Caffeine Intake ◽  
Anxiety States ◽  
Paranoid Delusion ◽  
Hospital Inpatients

AbstractCaffeine is a widely ingested and generally beneficial drug. However, when taken in excess, anxiety related symptoms become increasingly apparent. A case of caffeinism, which presented as a paranoid delusion, is reported as an extreme example of this.A study of 60 hospital inpatients revealed that about 40% of them consumed sufficient caffeine to produce symptoms of caffeinism. It is thus recommended that all patients should be questioned on their caffeine intake. Also, caffeinism should be considered as a differential diagnosis of anxiety states.

scholarly journals Remission of depression in patients with schizophrenia and comorbid major depressive disorder: results from the FACE-SZ cohort

2018 ◽  
Vol 213 (2) ◽  
pp. 464-470 ◽  
Author(s):  
Guillaume Fond ◽  
Laurent Boyer ◽  
Fabrice Berna ◽  
Ophélia Godin ◽  
Ewa Bulzacka ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Odds Ratio ◽  
Alcohol Misuse ◽  
Antidepressant Treatment ◽  
Major Depressive ◽  
Reactive Protein ◽  
Paranoid Delusion ◽  
Symptom Level ◽  
The Face

BackgroundMajor depressive disorder (MDD) is underdiagnosed and undertreated in schizophrenia, and has been strongly associated with impaired quality of life.AimsTo determine the prevalence and associated factors of MDD and unremitted MDD in schizophrenia, to compare treated and non-treated MDD.MethodParticipants were included in the FondaMental Expert Centers for Schizophrenia and received a thorough clinical assessment. MDD was defined by a Calgary score ≥6. Non-remitted MDD was defined by current antidepressant treatment (unchanged for >8 weeks) and current Calgary score ≥6.Results613 patients were included and 175 (28.5%) were identified with current MDD. MDD has been significantly associated with respectively paranoid delusion (odds ratio 1.8; P = 0.01), avolition (odds ratio 1.8; P = 0.02), blunted affect (odds ratio 1.7; P = 0.04) and benzodiazepine consumption (odds ratio 1.8; P = 0.02). Antidepressants were associated with lower depressive symptoms score (5.4 v. 9.5; P < 0.0001); however, 44.1% of treated patients remained in non-remittance MDD. Nonremitters were found to have more paranoid delusion (odds ratio 2.3; P = 0.009) and more current alcohol misuse disorder (odds ratio 4.8; P = 0.04). No antidepressant class or specific antipsychotic were associated with higher or lower response to antidepressant treatment. MDD was associated with Metabolic syndrome (31.4 v. 20.2%; P = 0.006) but not with increased C-reactive protein.ConclusionsAntidepressant administration is associated with lower depressive symptom level in patients with schizophrenia and MDD. Paranoid delusions and alcohol misuse disorder should be specifically explored and treated in cases of non-remission under treatment. MetS may play a role in MDD onset and/or maintenance in patients with schizophrenia.Declaration of interestNone.

Sign in / Sign up

Export Citation Format

Share Document